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Abstract
Apatite-wollastonite containing glass ceramic is considered to be difficult to resorb, but we
experienced the disappearance of the porous type of Apatite-wollastonite glass ceramic particles
. In this study, the resorption of porous apatite-wollastonite glass-ceramic implanted in the fe-
murs of rabbits was investigated, and the process was compared with beta-tricalcium phosphate,
a resorbable ceramics. Porous apatite-wollastonite glass-ceramic (70, 80, and 90% porosity) and
beta-tricalcium phosphate (75% porosity) were implanted in the femurs of Japanese white rabbits.
Samples were harvested and examined 0, 4, 8, 12, 24 and 36 weeks after implantation. Quanti-
tative analysis of the radiographic and histologic findings was performed with NIH Image soft-
ware. Radiographic examination demonstrated that the radiopacity and size of the porous apatite-
wollastonite glassceramic cylinders decreased gradually after implantation. Histologic examina-
tion revealed that the surface area of the apatite-wollastonite glass-ceramic cylinders decreased
continuously, and approached 20% of the original area 36 weeks after implantation. However, the
resorption rate of porous apatite-wollastonite glass-ceramic was slower than that of beta-tricalcium
phosphate. Toluidine blue staining showed abundant new bone formation on the surface of the
apatite-wollastonite glassceramic matrix. Considering its mechanical strength, gradual resorption
characteristics, and good osteochonductive activity, porous apatite-wollastonite glass-ceramic ap-
pears to be a suitable artificial bone substitutes.
KEYWORDS: apatite-wollastonite containing glass-ceramic (A-W GC), resorption, porous, ?-
tricalcium phosphate(?-TCR)
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Apatite-wollastonite containing glass ceramic is considered to be diﬃcult to resorb, but we experi-
enced the disappearance of the porous type of Apatite-wollastonite glass ceramic particles .
In this study, the resorption of porous apatite-wollastonite glass-ceramic implanted in the femurs of rabbits was investigated, and the process was compared withβ-tricalcium phosphate, a resorbable ceramics. Porous apatite-wollastonite glass-ceramic (70, 80, and 90  porosity) andβ-tricalcium phosphate(75  porosity)were implanted in the femurs of Japanese white rabbits. Samples were harvested and examined 0, 4, 8, 12, 24 and 36 weeks after implantation. Quantitative analysis of the radiographic and histologic ﬁndings was performed with NIH Image software. Radiographic examination demonstrated that the radiopacity and size of the porous apatite-wollastonite glass-
ceramic cylinders decreased gradually after implantation. Histologic examination revealed that the surface area of the apatite-wollastonite glass-ceramic cylinders decreased continuousl
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ched 20 of the original area 36 weeks after implantation. However, the resorption rate of porous apatite-wollastonite glass-ceramic was slower than that ofβ-tricalcium phosphate. Toluidine blue staining showed abundant new bone formation on the surface of the apatite-wollastonite glass-
ceramic matrix. Considering its mechanical strength, gradual resorption characteristics, and good osteochonductive activity, porous apatite-wollastonite glass-ceramic appears to be a suitable artiﬁcial bone substitutes.
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bone defect supplementation material. These ceramics are classiﬁed into 2 types:surface-bioactive ceramics or resorbable ceramics［1］. Apatite-wollastonite containing glass
 
ceramic (A-W GC) is classiﬁed as a surface bioactive ceramic it is considered to be stable in vivo,and diﬃcult to be resolved when implanted in bone［1-3］. When dense A-W GC (0.7  porosit
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the porous A-W GC particles that was implanted in the bone defects after the curettage of benign bone tumors was also observed in our department(unpublished paper).
Therefore, A-W GC could be a resorbable bioactive material when used as a porous condition. However,
there are few reports documenting the resorption of porous A-W GC that was implanted in bones［4, 5］. To our knowledge, the histologic and radiographic ﬁndings of the resorption of porous A-W GC implanted in vivo have not been investigated. In the current study, the resorp-
tion process of porous A-W GC that was implanted in the femur of rabbit was examined quantitatively and compared with that ofβ-tricalcium phosphate(β-TCP), a resorba-
ble bioactive ceramics.
Materials and Methods
 
Cylinders of porous A-W GC (4.4 mm diameter×9 mm length, mean pore size 200μm)
were prepared and provided by Nippon Electric Glass,
Co., Ltd. (Ohtsu, Japan). The chemical composition of A-W GC was 4.6  MgO, 44.9  CaO, 34.2  SiO?,
16.3  P?O?, 0.5  CaF?, and the crystallised glass-
ceramic consisted of 28  glass, 38  apatite［Ca?
(PO?)?(O, F?)］, and 34 β-wollastonite(SiO?・CaO).
Three diﬀerent porosities (70 , 80 , and 90 ) of A-W GC were used. Their compressive strengths
(mean±SD)were 20.1±6.3 MPa(AW70 ), 6.7±2.8 MPa(AW80 ), and 2.4±0.6 MPa(AW90 ), respec-
tively.
Cylinders of porousβ-TCP (4.4 mm diameter×9 mm length, pore size 100～400μm)were prepared and provided by OLYMPUS Co., Ltd. (Tokyo, Japan).
The chemical composition ofβ-TCP was Ca?(PO?)?.
The porosity was 75 , and compressive strength about 2 MPa.
Thirty eight, Japanese White Rabbits (3 to 4-month-old, male)weighing from 2.5 to 3.0 kg, were used. The rearing and the investiga-
tions were carried out according to the animal experimen-
tation established by our institute.
The rabbits were anaesthetized by the intramuscular injection of ketamine HCl (10 mg/kg body weight,
Sankyo Co., Tokyo, Japan)and the intravenous injection of pentobarbital sodium (25 mg/kg body weight,
Dainippon Co., Osaka, Japan). To prevent infection, an intramuscular injection of cefazolin sodium (20 mg/
kgbody weight, Fujisawa Co., Osaka, Japan)was used.
The operations were performed under standard aseptic conditions. Following a lateral incision along the leg,
abductor muscles were divided, and the distal aspect of the femur was exposed. A hole 4.5 mm in diameter and 10 mm in depth was drilled in the frontal direction,
leaving the medial cortex intact. After irrigation with saline, a cylinder of A-W GC orβ-TCP was pushed into the hole, and the periosteum and skin were closed in layers. The incision wound was sprayed with sterile plastic dressing (Nobecutane, Yoshitomi Co., Osaka,
Japan).
Three rabbits were used in each experiment. The animals were euthanized at 0, 2, 4, 8, 12, 24, and 36 weeks after implantation by an intravenous overdose injection of pentobarbital sodium.
Three of the original rabbits died, 1 at 2 weeks after the operation and 2 at 20 weeks after, because of local infection and unknown cause and they were replaced. The distal femurs, except those from the animals euthanized at 2 weeks, were radiographed in the antero-posterior direction with soft X-ray(Softex-CMB, SOFTEX Co.,
Tokyo, Japan). The radiographs were inputted with a scanner (Epson ES-2200;Seiko Epson Co., Suwa,
Japan). We chose the central part of the implants(25×
10 pixcels)as the ROI area. In addition, serial radiogra-
phic changes were examined using NIH image software
(U.S. National Institute of Health, Bethesda, MD USA).
The femurs were then cut into 5 mm sections, sagittal to the long axis, using a high speed,water-cooled circular saw with ﬁne diamond coating (BS-3000, EXAKT,
Norderstedt, Germany). The samples were ﬁxed in 70 methanol, dehydrated in serial concentrations of meth-
anol, and embedded in polymethylmetacrylate without decalciﬁcation. They were ground to a thickness of 30
μm using a grinding machine(MODEL 900, Grinder/
Polisher, South Bay Technology INC., San Clemente,
CA, USA). The surface was ﬁnished with number#2000 sandpaper and rapping ﬁlms(MARTO Rapping Film 3.0
μm, MARTO, Tokyo, Japan). The specimens were stained by toluidine blue staining and examined under light microscopy. The areas of A-W GC andβ-TCP and those of the newly formed bone, were quantitatively evaluated using the NIH Image software.
The distal femurs harvested at 8 weeks after implantation were ﬁxed in 70  methanol,
dehydrated in serial concentrations of methanol, and embedded in glycolmetacrylate without decalciﬁcation.
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 They were cut with a microtome(Leica/JUNG, model K, Wetzlar, Germany)in 5μm thin sections and stained for tartrate-resistant acid phosphatase(TRAP).
Results
 
The radiographic ﬁndings of the implants taken immediately and 24 weeks after implantation are shown in Fig. 1. The radiopacity and the areas of all the porous A-W GC andβ-TCP cylinders decreased remarkably at 24 weeks. Quantitative image analyses showed that the radiopacity of all the A-W GC cylinders decreased gradually and approached that of normal cancellous bone with time(Fig. 2). Although the initial values of the radiopacity diﬀered according to the porosity(70 ＞80 ＞90 ), they began to decrease as early as 4 weeks after implantation, and became almost
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Fig.1  Radiographic ﬁndings of the implants taken immediately and 24 weeks after implantation(40 kv, 10 mA, 10 sec). The radiopacity and the areas of the A-W GC andβ-TCP cylinders decreased remarkably at 24 weeks.
Fig.2  Chronological change of the radiopacity of the implants.
The value of 70% porosity A-W GC immediately after implantation was regarded as 100%.
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same values at 36 weeks of implantation. The radiopacity ofβ-TCP cylinders showed similar changes as those of A-W GC, but the changes were more rapid and marked changes were observed within 12 weeks after implantation
(Fig. 2).
Histologic examination revealed that the walls of A-W GC pores became thinner with time after implantation. Fig. 3 shows the serial changes of the areas of the implanted A-W GC and
β-TCP matrices measured by NIH Image software. The areas of the implants decreased continuously with time,
and approached that of 20 of the original ones 36 weeks after implantation. In compared withβ-TCP, the resorp-
tion rates of porous A-W GC were relatively gradual.
The mean resorption rates ( area/week)of the 70 ,
80 , 90  porosities A-W GC and 75  porosity
β-TCP cylinders were 2.56, 1.49, 0.97, and 3.17,
respectively. The resorption rate ofβ-TCP was about
 
Fig.3  Chronological change of the residual area of implants. The value of 70% porosity A-W GC immediately after implantation was taken as 100%.
Fig.4  Histologicalal ﬁndings of the implants(Toluidine blue staining, bars indicate 100μm, ×40)New bone formation was observed in pores of all the implants, especially in the 90% porosity A-W GC, at 4 weeks. The pore size ofβ-TCP was remarkably enlarged by 4 weeks.
At 24 weeks, all implants bonded with newly formed bone, but the implant areas decreased, especially in the 90% porosity A-W GC and in
β-TCP.
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1.2 times as that of AW70  and 3 times as that of the AW90  cylinders.
Toluidine blue surface staining showed new bone formation, mainly in the peripheral areas of the AW70 and AW80 cylinders, at 2 weeks after implantation. In AW90 , newly formed bone was observed even at the center of the cylinders at 2 weeks. Four weeks after implantation, newly formed bone had appeared in the pores of the center of the AW70  and AW80  cylin-
ders(Fig. 4). Direct contact between the newly formed
 
bone and A-W GC was observed. In AW90 , new bone formation was most evident at 4 weeks after im-
plantation, while, it was most prominent at 24 weeks in the AW70  cylinders.
Because of its rapid resorption, only a faintβ-TCP matrix was observed at 24 weeks. The area of the newly formed bone was less abundant inβ-TCP in compared with A-W GC during the entire experiment period(Fig.
5).
Numerous TRAP-positive multinucleate giant cells were observed on surface of the A-W GC andβ-TCP matrices at 8 weeks after implanta-
tion(Fig.6).
Discussion
 
Bioactive ceramics, deﬁned as ceramics that form a direct bond with living bone tissue, include surface-
bioactive ceramics ［e.g., Bioglass?, Ceravital?,
hydroxyapatite］and resorbable ceramics［e.g., β-TCP,
calcite］［3, 6］.
Dense A-W GC (0.7  porosity) is classiﬁed as a surface-bioactive ceramics and has been thought to be diﬃcult to resolve in vivo［1-3］. Conversely, A-W GC granules disappeared when they were implanted in bone defect as a porous material (70  porosity). However,
there have been no report examining the process of resorption of porous A-W GC in vivo［4, 5］. In the present study, we showed that the A-W GC was resor-
bed in vivo when it was implanted in bone as a porous
 
Fig.6  TRAP staining. TRAP-positive multinucleate cells with lengthening ﬁlopodia were observed both in the A-W GC(A)(×400)andβ-TCP
(B)(×400)ceramics. (Bars indicate 10μm).
Fig.5  Chronological change of the areass of newly formed bone.
Abundant new bone formation was observed in all the A-W GC cylinders. The quantity of newly formed bone was less abundant in
β-TCP than in A-W GC.
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material. This process was examined histologically and radiographically over time.
Under the experiment conditions used, most of the porous A-W GC matrix was resorbed in vivo by 36 weeks. In compared withβ-TCP, a resorbable bioactive ceramics, however, the resorption rates were gradual.
β-TCP(75 porosity)had almost disappeared complete-
ly by 24 weeks. Due to its rapid resorption and relatively poor new bone formation, only a faint mineralized matrix remained in theβ-TCP cylinders at 24 weeks. In con-
trast, an abundance of newly formed bone and residual A-W GC matrix were observed at 24 weeks, especially in the A-W GC with 70  porosity.
From the clinical point of view, a desirable artiﬁcial bone substitute should have mechanical properties as close as possible to those of the recipient bone, and after implantation, the artiﬁcial substitute should, hold its strength for an appropriate period and then be gradually replaced by the recipient skeletal tissue. Of the 4 mate-
rials that we examined(A-W GC with 70 , 80 , 90 porosities, andβ-TCP with 75  porosity), A-W GC with 70 porosity had the closest mechanical strength as that of normal human cancellous bone［7-9］. Consider-
ing its proper mechanical strength, relatively gradual resorption characteristics and good osteochonductive activity, A-W GC with 70  porosity could make a suitable artiﬁcial bone substitute.
Two major processes participate in the resorption of bioactive ceramics, a solution process and a cell-mediated process［10］. Partial dissolution of the ceramic in the solution process initiates the accumulation of phagocytos-
ing cells such as macrophages or osteoclasts around the material, and these cells play a central role in the resorp-
tion of the material(cell-mediated process).
As for A-W GC, the partial dissolution of the ceramics releases silicon and calcium ions in the surround-
ing ﬂuid and results in the precipitation of new apatite crystals on the surface of A-W GC［11-14］. In an in vitro experiment model, Yamada et al. found that actively moving osteoclasts produced many tracklike resorption lacunae on the bonelike apatite layer formed on A-W GC by a simulated body ﬂuid［15］. However, the role of cell-mediated resorption process in the in vivo incorporation of A-W GC was still unknown. On the one hand, Neo et al. reported that macrophages phagocyting crystals of A-W GC were rarely observed in vivo by transmission electron microscopy［12］. On the other hand, Ohsawa et al. reported that acid phosphatase
 
positive cells were observed on porous A-W GC in vivo
［5］. In the present study,many TRAP-positive multinu-
cleate giant cells (osteoclasts) were observed on the surface of A-W GC 8weeks after implantation. These cells were in direct contact with A-W GC, and some contained granules of A-W GC. These ﬁndings indicate that the porous A-W GC is resorbed in vivo when it is implanted in bone, both by the solution and cell-mediated processes.
In summary, the resorption of porous A-W GC has been demonstrated to take place in vivo, and the process has been compared quantitatively with that ofβ-TCP, a resorbable bioactive ceramics. In comparison with β-
TCP, cylinders of porous A-W GC were resorbed more gradually in vivo. Histologically, many TRAP-positive multinucleate giant cells (osteoclasts)were observed on the surface of A-W GC. Concurrently, abundant new bone formation was observed on A-W GC. Considering its mechanical strength, relatively gradual resorption characteristics and good osteochonductive activity, A-W GC with 70  porosity could make a suitable artiﬁcial bone substitute.
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